EDESA BIOTECH, INC. Receivables, Net, Current
EDESA BIOTECH, INC. (EDSA) had Receivables, Net, Current of $2.88 million as of 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2022-02-14
- 2021-12-31: Receivables, Net, Current $2.88M.
- 2021-09-30: Receivables, Net, Current $3.30M.
- 2021-06-30: Receivables, Net, Current $4.19M.
- 2021-03-31: Receivables, Net, Current $7.81M.
| Period end | Receivables, Net, Current | Receivables, Net, Current as first filed |
|---|---|---|
| 2021-12-31 | $2.88M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $3.30M 10-Q · filed 2022-02-14 | |
| 2021-06-30 | $4.19M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $7.81M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $168.03K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $87.45K 10-K · filed 2021-12-28 | |
| 2020-06-30 | $56.47K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $84.09K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $109.60K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $217.10K 10-K · filed 2020-12-07 | |
| 2019-06-30 | $345.01K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $40.05K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $7.34K 10-KT · filed 2019-12-12 | $71.69K 10-Q · filed 2019-02-05 |
| 2018-09-30 | $41.25K 10-Q · filed 2019-05-08 | |
| 2018-06-30 | $10.30K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $62.80K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $10.98K 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $1.29K 10-K · filed 2018-11-30 | |
| 2017-06-30 | $11.88K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $65.88K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $12.93K 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $85.81K 10-K · filed 2017-12-01 | |
| 2016-06-30 | $9.05K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $10.44K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $35.63K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $157.60K 10-K · filed 2016-12-14 | |
| 2015-06-30 | $112.96K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $16.56K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $35.98K 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $44.16K 10-K · filed 2015-12-14 | |
| 2014-08-31 | $56.58K 10-K · filed 2015-12-14 | |
| 2013-08-31 | $177.72K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |